Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.

The Journal of infusional chemotherapy

Volumn 6, Issue 4, 1996, Pages 211-216

  Chu, L ^a   Sutton, L M ^a   Peterson, B L ^a   Havlin, K A ^a   Winer, E P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL;

AMBULATORY CARE; ARTICLE; BREAST TUMOR; DISEASE COURSE; FEMALE; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; LIFE TABLE; METASTASIS; MORTALITY; PALLIATIVE THERAPY; PATHOLOGY; QUALITY OF LIFE; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

AMBULATORY CARE; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; LIFE TABLES; NEOPLASM METASTASIS; PALLIATIVE CARE; QUALITY OF LIFE; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030224230     PISSN: 10600051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)